Recent Searches
Trending
M&A outlook: stronger US deal market in 2026 despite mixed economic signals
28 Oct 2025 GrowthUS Healthcare Cyber Resilience Survey: Why elevating cybersecurity to a strategic priority can drive transformation
03 Nov 2025Beyond cost cutting: AI as the ultimate growth engine
03 Nov 2025 ConsultingEY-Parthenon professionals recognize that CEOs and business leaders are tasked with achieving maximum value for their organizations’ stakeholders in this transformative age. We challenge assumptions to design and deliver strategies that help improve profitability and long-term value.
Leading companies are taking big, transformative steps, redefining their purpose, embarking on end-to-end digital transformations and learning how to achieve disruptive innovation in a rapidly shifting market environment.
We have the breadth of perspectives and depth of experience to provide strategic advice to help achieve optimal — and sustainable — results.
We create a custom approach tailored to each client’s unique situation and bring extensive business and sector experience with tested analytical techniques. As experienced advisors to the C-suite, EY-Parthenon helps you answer:
How EY-Parthenon can help
Find out how we can help your business drive innovation and reimagine business models for future readiness.
Read moreThe Geostrategic Business Group can help translate geopolitical insights into business strategy to help manage political risk. Find out how.
Read moreOur EY Growth Platforms team uses neurosymbolic AI to help companies turn diverse data into tailored AI products for revenue and profit growth. Learn how.
Read moreLearn more about how EY-Parthenon Software Strategy Consulting teams apply real-world software CTO and CPO expertise to drive value.
Read moreOur Commercial Consulting Services teams help you realize enterprise growth, improve profitability, and extend customer and shareholder value. Learn more.
Read moreEY-Parthenon sector strategy consulting teams have deep sector strategy experience and can help your business challenge the status quo. Learn more.
Read moreOur latest thinking
US M&A activity insights: October 2025
Read the latest Merger Monthly, with insights on recent US M&A activity and what M&A trends to expect as we look ahead.
AI-powered growth: GenAI as a new engine of US economic performance
Discover how Generative AI is fueling significant AI-powered growth in the US economy, with a rapid rise in AI adoption across industries.
How to optimize your global strategy amid asymmetric globalization
Exploring future scenarios reveals divergent paths for geopolitics, economic policies, sector trajectories and company strategies. Learn more.
M&A outlook: stronger US deal market in 2026 despite mixed economic signals
The EY-Parthenon Deal Barometer, informed by our US economic outlook, predicts robust US deal volume growth through 2026.
Does today’s disruption provide the blueprint for tomorrow’s growth?
EY-Parthenon CEO Survey September 2025 reveals how leaders build confidence, resilience, and growth strategies amid disruption and transformation.
Macro bites: Driving growth strategies in the tech sector amid volatility
Despite headwinds such as tariffs and policy shifts, using unique strategies for growth in tech can drive success. Learn more in this Macro Bites episode.
Rivada is reimagining wireless internet as a commodity
By leveraging AI and automation, patient diagnostics have picked up pace in a health care testing company. Learn more in this case study.
Global economic outlook: slowdown amid uncertainty
Global economic activity is expected to slow in 2025–26 due to trade tensions, rising bond yields and extreme policy uncertainty. Read our outlook.
What type of corporate venture builder are you?
Explore the different types of corporate venture builders and discover which model aligns with your organization's innovation strategy and goals.
Learn key steps for corporate venture building to unlock value in different sectors.
Driving the next S-curve of market capital growth for corporates
Corporate venture building can unlock hidden market value for companies, driving growth and shareholder returns through strategic, organic transactions.
The five habits of successful Geostrategists
All companies are shifting strategies to adapt to geopolitical risk. Here is how to invest more efficiently and strategically than your competitors. Read more.
Macro bites: Corporate venture building amid economic and geopolitical uncertainty
EY-Parthenon leaders discuss how corporate venture building can become a key part of a company’s growth strategy.
Macro bites: enterprise transformation in financial services
Financial services organizations are facing economic uncertainty. Learn more about how the winners are becoming less risk averse, in a data-driven way.
Macro Bites: Signals show steady boost in 2025 M&A deal activity
Learn about the 2025 M&A forecast and what companies should consider when preparing for dealmaking.
Why private equity portfolio companies need a better pricing framework now
Download the 2025 EY-Parthenon PE Pricing Report to learn how private equity portfolio companies can build value with better pricing strategies.
Enterprise software carve-outs: insights for success, distilled
Discover how leading enterprise software companies use carve-out divestitures to innovate, enhance shareholder value, and outperform peers. Learn more.
How to be a savvy technology M&A dealmaker
The EY-Parthenon Technology Corporate Development Survey confirms seven key traits of companies that succeed with mergers and acquisitions (M&A). Read more.
Data center development: mastering the stabilized asset cycle
Avoid pitfalls and unlock value through a multidisciplinary, three-stage strategy. Learn more.
Three disrupters that will reshape the global food system
Global food system faces changes in energy, protein tech, and geopolitics; companies can adapt with new strategies for growth and resilience.
How to manage geopolitical risk in the new era of globalization
Geostrategy by Design: Managing Geopolitical Risk is a new book from EY-Parthenon team that explores the topic. Learn more.
How corporate venture builders can unlock the next $1 billion in value
Adopting a corporate venture building approach can help companies launch their next corporate unicorn to turbocharge market cap growth.
Four actions to pioneer responsible AI in any industry
Leaders in tech must adopt ethical AI frameworks to ensure responsible innovation. Learn more.
The future of commercial health benefits
Learn about the future of commercial benefits from the 2024 EY-Parthenon Employee Health Benefits Survey.
Macro Bites: The economy’s impact on private equity investment strategy
Learn how private equity investment strategy is adapting as elevated costs of capital leads firms to hold investments longer.
How AI in customer service can turn pain points into wow moments
AI in customer service can provide data-driven customization, speed and innovation that helps sales and marketing. Read more.
Macro Bites: How is M&E navigating the streaming services revolution?
Learn how media and entertainment (M&E) companies are navigating the streaming services revolution in an unbalanced environment.
How global business leaders can harness the power of GenAI
Learn about five strategic lessons for business leaders seeking to successfully utilize the power of GenAI.
GenAI risks and challenges for the economy
Learn about the expected impact of GenAI on the labor market by exploring our four key findings regarding GenAI use.
Macro Bites: Capital allocation priorities
What are companies’ capital allocation priorities as interest rates are poised to fall? Watch the episode.
How divestitures can fire up growth with a focus on commercial strategy
CEOs and their teams can prioritize commercial strategy when planning a carve-out or other separation to help ignite future growth. Read more.
How GenAI strategy can transform innovation
Companies considering or investing in a transformative GenAI strategy should tie generative artificial intelligence use cases to revenue, cost and expense. Learn more
Strategies for successful corporate separations
Gain competitive advantage with valuable insights from 160+ corporate separations, including spin offs, carve outs, optimal timing, and value maximization.
How pharma can benefit from using GenAI in drug discovery
Using GenAI in drug discovery is a hot topic in the pharmaceutical industry, with speed and cost savings seen as potential benefits. Learn more.
